TrialHaematologica2012

A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy.

Michael Lübbert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.